Abstract
Objective
Bariatric surgery not always results in satisfactory excess weight loss (EWL) in severe obesity. Given the economic and clinical costs of bariatric surgery failure, defining predictors of successful EWL represents a relevant clinical issue for the health system to select patients benefiting from operation.
Methods
By ELISA and Western blot analyses, we assessed the predicting value of pre-operative adiponectin (APN) locally produced in abdominal visceral (VAT) and subcutaneous (SAT) adipose tissue versus plasma levels as a novel sex-linked biomarker of EWL at different time points of follow up (6–24 months) after bariatric surgery in 43 patients (56% females) affected by severe obesity undergoing a small pilot observational study.
Results
VAT-APN was lower in females and represented the only marker significantly correlated with EWL. In females, VAT-APN in the distribution upper quartile but not baseline BMI retained a statistically significant correlation with EWL at any time points (6–24 months) at multivariate analysis. The best VAT-APN cut-off value to predict 95% EWL at 12 months from surgery (98% accuracy, 100% sensitivity, 94% specificity, p = 0.010) was 5.1 µg/mg.
Conclusions
In this very preliminary study, APN in VAT rather than its circulating or subcutaneous levels predicts EWL after bariatric surgery as an independent factor in the female sex only, thus contributing to identify those patients who could much benefit from surgery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The data of this study are available from the corresponding author, ML, upon reasonable request.
References
Pinhas-Hamiel O, Hamiel U, Bendor CD, Bardugo A, Twig G, Cukierman-Yaffe T. The global spread of severe obesity in toddlers, children, and adolescents: a systematic review and meta-analysis. Obes Facts. 2022;15:118–34.
Di Lorenzo N, Antoniou SA, Batterham RL, Busetto L, Godoroja D, Iossa A, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020;34:2332–58.
Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N. Engl J Med. 2007;357:753–61.
Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, et al. Weight and metabolic outcomes 12 years after gastric bypass. N. Engl J Med. 2018;378:93–96.
Kauppila JH, Markar S, Santoni G, Holmberg D, Lagergren J. Temporal changes in obesity-related medication after bariatric surgery vs no surgery for obesity. JAMA Surg. 2023;158:817–23.
Yarigholi F, Bahardoust M, Mosavari H, Tehrani FM, Gholizadeh H, Shahmiri SS, et al. Predictors of weight regain and insufficient weight loss according to different definitions after sleeve gastrectomy: a retrospective analytical study. Obes Surg. 2022;32:4040–6.
El Ansari W, Elhag W. Weight regain and insufficient weight loss after bariatric surgery: definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge gaps-a scoping review. Obes Surg. 2021;31:1755–66.
Pokala B, Hernandez E, Giannopoulos S, Athanasiadis DI, Timsina L, Sorg N, et al. Early postoperative weight loss predicts nadir weight and weight regain after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc. 2023;37:4934–41.
Athanasiadis DI, Martin A, Kapsampelis P, Monfared S, Stefanidis D. Factors associated with weight regain post-bariatric surgery: a systematic review. Surg Endosc. 2021;35:4069–84.
Faraj M, Havel PJ, Phélis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–602.
Williams RL, Wood LG, Collins CE, Morgan PJ, Callister R. Energy homeostasis and appetite regulating hormones as predictors of weight loss in men and women. Appetite. 2016;101:1–7.
Di Franco A, Guasti D, Mazzanti B, Ercolino T, Francalanci M, Nesi G, et al. Dissecting the origin of inducible brown fat in adult humans through a novel adipose stem cell model from adipose tissue surrounding pheochromocytoma. J Clin Endocrinol Metab. 2014;99:E1903–12.
Di Franco A, Guasti D, Squecco R, Mazzanti B, Rossi F, Idrizaj E, et al. Searching for classical brown fat in humans: development of a novel human fetal brown stem cell model. Stem Cells. 2016;34:1679–91.
Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care. 2006;29:2427–32.
Lee S, Bacha F, Gungor N, Arslanian S. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006;29:51–56.
Alser M, Elrayess MA. From an apple to a pear: moving fat around for reversing insulin resistance. Int J Environ Res Public Health. 2022;19:14251.
Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001;50:425–35.
Delaney KZ, Santosa S. Sex differences in regional adipose tissue depots pose different threats for the development of Type 2 diabetes in males and females. Obes Rev. 2022;23:e13393.
Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol. 2004;219:9–15.
Reneau J, Goldblatt M, Gould J, Kindel T, Kastenmeier A, Higgins R. et al. Effect of adiposity on tissue-specific adiponectin secretion. PLoS One. 2018;13:e0198889.
Drolet R, Richard C, Sniderman AD, Mailloux J, Fortier M, Huot C, et al. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes. 2008;32:283–91.
Sarafidis PA, McFarlane SI, Bakris GL. Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome. Curr Diab Rep. 2006;6:219–24.
Drolet R, Bélanger C, Fortier M, Huot C, Mailloux J, Légaré D, et al. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring). 2009;17:424–30.
Acknowledgements
The authors thank Dr. Enrico Facchiano (General and Bariatric Surgery Unit, Santa Maria Nuova Hospital) for his valuable collaboration.
Funding
This publication was produced with the co-funding European Union—Next Generation EU, in the context of The National Recovery and Resilience Plan, Investment 1.5 Ecosystems of Innovation, Project Tuscany Health Ecosystem (THE), CUP: B83C22003920001.
Author information
Authors and Affiliations
Contributions
GC, GQ, ML designed and conceive the study; GQ, NG, MaLu were responsible for patient selection and surgery and obtained patient samples; DAG, LF, AP, LG conducted experiments; GC, GQ, NG, collected patient data; GC, ML analysed data and wrote the manuscript; MM, ML interpreted results, revised the draft manuscript critically for important intellectual content. All authors were involved in writing the paper and had final approval of the submitted version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cantini, G., Quartararo, G., Ghezzi, N. et al. Visceral adipose tissue adiponectin predicts excess weight loss after bariatric surgery in females with severe obesity. Int J Obes 48, 247–253 (2024). https://doi.org/10.1038/s41366-023-01406-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-023-01406-1
This article is cited by
-
Reevaluating Adiponectin’s impact on obesity hypertension: a Chinese case-control study
BMC Cardiovascular Disorders (2024)